Project Details
Description
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
| Status | Active |
|---|---|
| Effective start/end date | 9/11/23 → 8/31/24 |
Funding
- MAYO CLINIC ROCHESTER
- NIH NATIONAL CANCER INSTITUTE (NCI)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.